Correlation Between NeoGenomics and Verve Therapeutics
Can any of the company-specific risk be diversified away by investing in both NeoGenomics and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeoGenomics and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeoGenomics and Verve Therapeutics, you can compare the effects of market volatilities on NeoGenomics and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeoGenomics with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeoGenomics and Verve Therapeutics.
Diversification Opportunities for NeoGenomics and Verve Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NeoGenomics and Verve is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding NeoGenomics and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and NeoGenomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeoGenomics are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of NeoGenomics i.e., NeoGenomics and Verve Therapeutics go up and down completely randomly.
Pair Corralation between NeoGenomics and Verve Therapeutics
Considering the 90-day investment horizon NeoGenomics is expected to generate 1.01 times less return on investment than Verve Therapeutics. But when comparing it to its historical volatility, NeoGenomics is 3.42 times less risky than Verve Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Verve Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 642.00 in Verve Therapeutics on September 12, 2024 and sell it today you would earn a total of 30.00 from holding Verve Therapeutics or generate 4.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
NeoGenomics vs. Verve Therapeutics
Performance |
| Timeline |
| NeoGenomics |
| Verve Therapeutics |
NeoGenomics and Verve Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NeoGenomics and Verve Therapeutics
The main advantage of trading using opposite NeoGenomics and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeoGenomics position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.| NeoGenomics vs. Natera Inc | NeoGenomics vs. Qiagen NV | NeoGenomics vs. Neogen | NeoGenomics vs. Guardant Health |
| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |